Antibodies 2022, 11(3), 56; https://doi.org/10.3390/antib11030056 - 26 Aug 2022
Best Paper Award
Dear Colleagues,
We are pleased to announce the winner of the Antibodies 2021 Best Paper Award. All papers published from 1 January 2021 to 31 December 2021 in Antibodies were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, one paper was selected.
Paper Title: “HDX-MS for Epitope Characterization of a Therapeutic ANTIBODY Candidate on the Calcium-Binding Protein Annexin-A1”
By Marius Gramlich, Henry C. W. Hays, Scott Crichton, Philipp D. Kaiser, Anne Heine, Nicole Schneiderhan-Marra, Ulrich Rothbauer, Dieter Stoll, Sandra Maier and Anne Zeck
Antibodies 2021, 10(1), 11; doi:10.3390/antib10010011
The winner will receive CHF 500 and a chance to publish a paper in Antibodies before 30 December 2024 after peer review.
Please join us in congratulating the winners of Antibodies 2021 Best Paper Award. We would also like to take this opportunity to thank all of our authors for your continued support of Antibodies.
Kind regards,
Antibodies Editorial Office
Antibodies 2021 Best Paper Award
Eligibility and Requirements
– All papers published in Antibodies will be eligible (Both regular and Special Issue submissions).
Past Winners
Year:
Winner
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
Award Committee
Prof. Arne Skerra
Chairman
Dr. Pablo Engel
Department of Biomedical Sciences
Prof. Dr. Buyong Ma
Prof. Mattias Collin
Lund University
Winner
Mark L. Chiu
Drug Product Development Science, Janssen Research & Development, LLC, Malvern, PA 19355, USA
